A phase I study of sunitinib combined with modified FOLFOX6 in patients with advanced solid tumors. [electronic resource]
Producer: 20120924Description: 65-74 p. digitalISSN:- 1432-0843
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Area Under Curve
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Fatigue -- chemically induced
- Female
- Fluorouracil -- administration & dosage
- Humans
- Indoles -- administration & dosage
- Leucovorin -- administration & dosage
- Male
- Metabolic Clearance Rate
- Middle Aged
- Neoplasms -- drug therapy
- Neutropenia -- chemically induced
- Organoplatinum Compounds
- Oxaliplatin
- Pyrroles -- administration & dosage
- Sunitinib
- Thrombocytopenia -- chemically induced
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.